Shawn Novick

Shawn Novick is a biotherapeutics professional with over 30 years of experience working at Immunex, Amgen, and Seattle Genetics in analytical development and quality control. At Seattle Genetics Shawn led the QC department and helped establish testing requirements for ADCs and ADC components. Shawn led the efforts at SeaGen to define specification setting guidelines and is co-author on papers defining and providing guidance on the subject. Currently Shawn is the Chair of the Biotherapeutics Committee for IABS and is consulting with BioPhia.